|
||||||||||||
 |
||||||||||||
|
||||||||||||
Top Stories
Immunize.org Pages and Handouts
Vaccine Information Statements
Featured Resources
Notable Publications
Upcoming Events
Top Stories
Spanish versions of new Vaccine Information Statement for RSV vaccine for older adults and updated multi-vaccine VIS for infants now available
Immunize.org posted two new Spanish translations of Vaccine Information Statements (VISs), published by CDC. The new Spanish translation of the respiratory syncytial virus (RSV) vaccine VIS reflects the 2023 ACIP recommendation for RSV vaccination for adults age 60 years or older using shared clinical decision-making. The new Spanish translation of “Your Child’s First Vaccines” VIS provides information on diphtheria, tetanus, pertussis, Hib, hepatitis B, pneumococcal, and poliovirus vaccines, including 20-valent pneumococcal conjugate vaccine (PCV20) as an option for vaccination.
Related Links
Immunization advocates: registration is open for the 16th National Conference for Immunization Coalitions and Partnerships to be held April 9–11, 2024, in Philadelphia Registration for the 16th National Conference for Immunization Coalitions and Partners (NCICP) is now open. The NCICP is the only conference solely dedicated to collaboration and partnership to improve immunization uptake, educate the community, and prevent the spread of disease. The Pennsylvania Immunization Coalition is proud to host the event on April 9–11 in Philadelphia, PA, at the Loews Hotel.
“Safety of mRNA COVID-19 Vaccines in Children”: watch the 3-minute answer, part of the Ask the Experts Video Series on Facebook, LinkedIn, X (Twitter), YouTube, and Instagram
Immunize.org's social media channels make it easy for you to learn a little more every day. This week, our featured episode from the Ask the Experts Video Series is Safety of mRNA COVID-19 Vaccines in Children. This is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions. Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
Back to top
Immunize.org’s Hepatitis B Birth Dose Honor Roll recognizes 580 institutions, including four renewing honorees Immunize.org is pleased to renew four institutions’ Hepatitis B Birth Dose Honor Roll status, retaining their standing among 580 honorees. The birthing institutions are listed below with their reported hepatitis B birth dose coverage rates in parentheses.
 The Honor Roll is a key part of Immunize.org’s initiative urging the nation’s hospitals to Give Birth to the End of Hep B. Hospitals and birthing centers are recognized for attaining high coverage for hepatitis B vaccine at birth and meeting additional criteria. To learn whether your organization qualifies and to access the application form, please see Hepatitis B Birth Dose Honor Roll online. Honorees receive an 8.5" x 11" color certificate suitable for printing and framing. And their acceptance is announced through Immunize.org’s social media channels and to IZ Express’s 55,000+ readers. Please visit the Hepatitis B Birth Dose Honor Roll web page that lists these institutions and celebrates their vigorous efforts to protect infants from perinatal hepatitis B transmission. Related Immunize.org Resources
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Pages and Handouts
Immunize.org reviewed, updated, and posted five of its influenza-related clinical resources for the 2023–2024 season. The revised materials and any additional edits are listed below.
Immunize.org recently updated its resource for the public: Varicella (Chickenpox): Questions and Answers. The document now includes current epidemiologic information and a QR code linking users to the PDF of the current document. Related Links
Back to top
Immunize.org's popular Ask the Experts: Travel Vaccines web page was updated with a thorough review. Information was added about the temporary unavailability of FDA-licensed cholera vaccine in the United States and the fact that a multiyear yellow fever vaccine shortage has fully resolved. Basic questions and answers were added about the newly recommended vaccine against tick-borne encephalitis (TBE, Ticovac, Pfizer). Related Links
Back to top
IZ Express regularly summarizes Immunize.org’s new and updated educational materials and web pages. All Immunize.org materials are free to distribute. In recent weeks, Immunize.org updated or created new helpful materials:
Vaccine Information Statements
IZ Express regularly provides readers with information about new and updated Vaccine Information Statements (VISs) and their translations.
Hepatitis B Vaccine (view in English):
Featured Resources
CHOP’s PolicyLab and Vaccine Education Center release report on increasing vaccination rates on college campuses
The Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center (VEC), along with CHOP's PolicyLab, issued an Evidence to Action Brief Higher Education Student Vaccination Policies: How Administrators Can Encourage Vaccine Uptake. The brief lists recommendations for college and university health administrators to strengthen vaccine uptake among students. Back to top
Listen to the newest episode of Unity’s FACTSinnated podcast on the FDA’s role in increasing vaccine confidence with Dr. Peter Marks The Unity Consortium’s podcast, FACTSinnated, is centered around “myth-busting” commonly held misconceptions surrounding vaccines—particularly adolescent and young adult vaccines. Unity’s most recent episode, Considering FDA’s Role in Increasing Vaccine Confidence amongst Parents, Adolescents, and Young Adults, features Peter Marks, MD, PhD, Director of the FDA’s Center for Biologics Evaluation and Research (CBER). During the podcast, Dr. Marks discusses how the FDA is keeping adolescents and young adults in mind as they continue to tackle vaccine development.
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever. The website is divided into five easy-to-access sections:
The site also categorizes materials according to whether they are primarily of interest to providers, to adolescents, or to parents.
Notable Publications “‘They’ve All Endorsed It . . . but I’m Just Not There:’ A Qualitative Exploration of COVID-19 Vaccine Hesitancy Reported by Black and Latinx Individuals” published in BMJ Open
In the July 20 issue, BMJ Open published ‘They’ve All Endorsed It . . . but I’m Just Not There:’ A Qualitative Exploration of COVID-19 Vaccine Hesitancy Reported by Black and Latinx Individuals. A portion of the abstract appears below. Upcoming Events
Virtual: Watch the ACIP meeting to discuss updated COVID-19 vaccines for fall 2023, September 12, 10:00 a.m. (ET)
CDC will convene its Advisory Committee on Immunization Practices (ACIP), September 12, 10:00 a.m.–4:00 p.m. (ET). The agenda will focus on recommendations for COVID-19 vaccines that target the XBB variants of SARS-CoV-2.
For more upcoming events, visit our Calendar of Events.
|
||||||||||||
|
